<DOC>
	<DOCNO>NCT02454140</DOCNO>
	<brief_summary>This study determine maximum tolerate dose ( MTD ) five fraction stereotactic radiotherapy ( SBRT ) pancreatic cancer .</brief_summary>
	<brief_title>Stereotactic Body Radiotherapy Dose Escalation Pancreatic Cancer</brief_title>
	<detailed_description>This trial design find maximum tolerate dose radiation fix 5-fraction SBRT regimen escalate dose 40 Gy 5 fraction , 60 Gy 5 fraction , 5 Gy interval .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Diagnosis : Histologicallyproven invasive adenocarcinoma pancreas . Disease Status : Medically unresectable ( stage ) , locally advanced ( stage III ) . Tumor Location : Primary tumor may locate anywhere pancreas . Treatment eligibility : The patient must able fiducial marker implant pancreatic tumor , receive radiation regimen specify protocol . Performance Level : Karnofsky Performance Status ≥ 60 Adequate Renal Function Defined As : Serum creatinine ≤ 1.5 x upper limit normal Informed Consent : All subject must sign write informed consent . Pregnancy BreastFeeding : Pregnant breastfeed woman enter study due risk fetal teratogenic adverse event . ( Note : Serum Pregnancy test must obtain woman child bear potential ) . Sexually active female may participate unless agree use effective contraceptive method ( abstinence , diaphragm , condom , intrauterine device ) prevent pregnancy duration study . Life expectancy &lt; 6 month The patient prior radiation therapy thorax upper abdomen . Incarcerated individual Subjects unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>